2-羥基-5-(4-三氟甲基四氟苄胺基)苯甲酸
 | |
| 法律規範狀態 | |
|---|---|
| 法律規範 |
|
| 識別資訊 | |
| |
| CAS編號 | 640290-67-1  |
| PubChem CID | |
| 化學資訊 | |
| 化學式 | C15H8F7NO3 |
| 莫耳質量 | 383.22 g·mol−1 |
| 3D模型（JSmol） | |
| |
2-羥基-5-(4-三氟甲基四氟苄胺基)苯甲酸（商品名：Nelonemdaz）是一種實驗性藥物，用作自由基削減劑和GRIN2B的選擇性拮抗劑。據推測，它對最近經歷過中風的人具有神經保護作用。[1][2][3][4]
它可以4-三氟甲基四氟苄溴和5-胺基-2-羥基苯甲酸為原料反應製得。[5]
參考文獻
- ^ Xu, Xiumei; Chen, Mingyu; Zhu, Dongya. Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity and free radical. Stroke and Vascular Neurology. 13 October 2023: svn–2023–002671. doi:10.1136/svn-2023-002671
.
- ^ Lee, Jin Soo; Lee, Ji Sung; Gwag, Byoung Joo; Choi, Dennis W; An, Chun San; Kang, Hyun Goo; Song, Tae-Jin; Ahn, Seong Hwan; Kim, Chang Hun; Kwon, Sun U. Abstract TP15: Rationale And Ongoing Status In A Phase 3 Trial Of Nelonemdaz, A Novel Neuroprotection Drug, For Patients With Acute Ischemic Stroke And Reperfusion. Stroke. February 2023, 54 (Suppl_1). doi:10.1161/str.54.suppl_1.TP15.
- ^ Lee, Jin Soo; Lee, Ji Sung; Gwag, Byoung Joo; Choi, Dennis W.; An, Chun San; Kang, Hyun Goo; Song, Tae-Jin; Ahn, Seong Hwan; Kim, Chang Hun; Shin, Dong-Ick; Kwon, Sun U. The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy. Journal of Stroke. 31 January 2023, 25 (1): 160–168. doi:10.5853/jos.2022.02453 .
- ^ Hong, Ji Man; Lee, Jin Soo; Lee, Yeong-Bae; Shin, Dong Hoon; Shin, Dong-Ick; Hwang, Yang-Ha; Ahn, Seong Hwan; Kim, Jae Guk; Sohn, Sung-Il; Kwon, Sun U.; Lee, Ji Sung; Gwag, Byoung Joo; Chamorro, Ángel; Choi, Dennis W.; Chammorro, Ángel; Kim, Eung Yeop; Choi, Jin Wook; Yeo, Min-Ju; Kwak, Jaehyuk; Lee, Sung Eun; Hong, Jeong-Ho; Lee, Sangkil; Lee, Yoon-Joo; Lee, Min-Joo. Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial. Stroke. November 2022, 53 (11): 3250–3259. doi:10.1161/STROKEAHA.122.039649 .
- ^ Gwag, Byoung Joo; Yoon, Sung Hwa; Moon, Ho Sang; Park, Eun Chan; Won, Seok Joon; Lee, Young Ae; Lee, Hae Un. Preparation of tetrafluorobenzyl derivatives and pharmaceutical composition for treatment of neurodegenerative diseases in the central nervous system. 2003. WO2004000786.
 | 這是一篇與醫學相關的小作品。你可以透過編輯或修訂擴充其內容。 |